DIFFERENTIAL DIAGNOSIS OF BIPOLAR DISORDER AND UNIPOLAR DEPRESSION BY BLOOD RNA EDITING… Application WO-2021089866-A1 World Intellectual Property Organisation (WIPO) 14 May 2021
DIAGNOSING OF MOOD DISORDERS USING BLOOD RNA EDITING BIOMARKERS Application WO-2021089865-A1 World Intellectual Property Organisation (WIPO) 14 May 2021
DIFFERENTIAL DIAGNOSIS OF BIPOLAR DISORDER AND UNIPOLAR DEPRESSION BY BLOOD RNA EDITING… Application EP-3819387-A1 European Patent Office 12 May 2021
DIAGNOSING OF MOOD DISORDERS USING BLOOD RNA EDITING BIOMARKERS Application EP-3819386-A1 European Patent Office 12 May 2021
ANTIGEN BINDING AGENTS THAT BIND CD277 AND USES THEREOF Application WO-2020033923-A1 World Intellectual Property Organisation (WIPO) 13 Feb 2020
Compositions including triciribine and epidermal growth factor receptor inhibitor… Grant US-9655914-B2 United States of America 23 May 2017
Effective treatment of tumors and cancer with triciribine and related compounds Grant US-9518079-B2 United States of America 13 Dec 2016
Compositions including triciribine and taxanes and methods of use thereof Grant US-9498492-B2 United States of America 22 Nov 2016
Compositions including triciribine and trastuzumab and methods of use thereof Grant US-9486522-B2 United States of America 08 Nov 2016
Compositions including triciribine and bortezomib and derivatives thereof and methods of… Grant US-9486492-B2 United States of America 08 Nov 2016
Compositions including triciribine and one or more platinum compounds and methods of use… Grant US-9486470-B2 United States of America 08 Nov 2016
Compositions including triciribine and epidermal growth factor receptor inhibitor… Grant US-9265783-B2 United States of America 23 Feb 2016
Compositions including triciribine and one or more platinum compounds and methods of use… Grant US-9211299-B2 United States of America 15 Dec 2015
Compositions including triciribine and bortezomib and derivatives thereof and methods of… Grant US-9192645-B2 United States of America 24 Nov 2015
Compositions including triciribine and trastuzumab and methods of use thereof Grant US-9186403-B2 United States of America 17 Nov 2015
Effective treatment of tumors and cancer with triciribine and related compounds Grant US-9115162-B2 United States of America 25 Aug 2015
Compositions including triciribine and taxanes and methods of use thereof Grant US-9101641-B2 United States of America 11 Aug 2015
METHODS AND KITS FOR DETERMINING WHETHER A NK CELL IS ACTIVATED AND IS ABLE TO PROLIFERATE Application WO-2014207009-A2 World Intellectual Property Organisation (WIPO) 31 Dec 2014
Compositions including triciribine and bortezomib and derivatives thereof and methods of… Grant US-8865666-B2 United States of America 21 Oct 2014
Compositions including triciribine and taxanes and methods of use thereof Grant US-8691779-B2 United States of America 08 Apr 2014
Compositions including triciribine and one or more platinum compounds and methods of use… Grant US-8673868-B2 United States of America 18 Mar 2014
Compositions including triciribine and epidermal growth factor receptor inhibitor… Grant US-8673867-B2 United States of America 18 Mar 2014
Compositions including triciribine and trastuzumab and methods of use thereof Grant US-8623834-B2 United States of America 07 Jan 2014
Effective treatment of tumors and cancer with triciribine and related compounds Grant US-8435959-B2 United States of America 07 May 2013
GalNAc specific binding molecules and uses thereof Application EP-2463300-A2 European Patent Office 13 Jun 2012
Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases Grant US-7993639-B2 United States of America 09 Aug 2011
Heterocyclic compounds as pSTAT3/IL-6 inhibitors Grant US-7786142-B2 United States of America 31 Aug 2010
GalNAc specific binding molecules and uses thereof Application EP-2113515-A2 European Patent Office 04 Nov 2009
Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases Grant US-7416723-B2 United States of America 26 Aug 2008